Interstitial Cystitis
Clinical manifestations of interstitial cystitis and bladder pain syndrome: Analysis of a patient registry in Japan.
October 20, 2024
Purine nucleoside phosphorylase inhibition is an effective approach for the treatment of chemical hemorrhagic cystitis.
October 18, 2024
Necrotizing Fasciitis Mimicking Interstitial Cystitis: An Atypical Clinical Presentation.
October 13, 2024
APRIL/BAFF upregulation is associated with clonal B-cell expansion in Hunner-type interstitial cystitis.
October 13, 2024
Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome.
October 6, 2024
Definition Change and Update of Clinical Guidelines for Interstitial Cystitis and Bladder Pain Syndrome.
October 6, 2024
Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study.
October 6, 2024
Purine nucleoside phosphorylase as a target for the treatment of interstitial cystitis/bladder pain syndrome with and without Hunner lesions.
September 22, 2024
Coping With Interstitial Cystitis/Bladder Pain Syndrome.
September 18, 2024
Cdk1/p53/p21 feedback loop mechanisms in the pathogenesis of interstitial cystitis/bladder pain syndrome.
August 23, 2024
Characterization and Therapeutic Potential of Curcumin-Loaded Cerium Oxide Nanoparticles for Interstitial Cystitis Management.
August 23, 2024